Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 7.85% is 79% below its 5-year average of 37.25%, near the low end of its 5-year range (0.24%–86.37%).
As of the fiscal period ended Tuesday, June 30, 2026. 68.56% below its 12-month average of 24.97%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.85%.
DEBT TO ASSETS RATIO
7.85%
DEBT TO ASSETS RATIO AVG TTM
24.97%
DEBT TO ASSETS RATIO AVG 3Y
31.75%
DEBT TO ASSETS RATIO AVG 5Y
37.25%
DEBT TO ASSETS RATIO AVG 10Y
19.62%
DEBT TO ASSETS RATIO AVG 15Y
9.31%
DEBT TO ASSETS RATIO AVG 20Y
7.97%
CURRENT VS TTM AVG
-68.56%
CURRENT VS 3Y AVG
-75.28%
CURRENT VS 5Y AVG
-78.93%
CURRENT VS 10Y AVG
-60.00%
CURRENT VS 15Y AVG
-15.66%
CURRENT VS 20Y AVG
-1.46%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+7749.23%
vs the sector median at left
Achieve Life Sciences, Inc.
Market Cap
$736.07M
Debt to Assets Ratio
7.85%
TTM Avg
24.97%
3Y Avg
31.75%
5Y Avg
37.25%
Market Cap
$726.81M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$751.69M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$717.44M
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$761.28M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$766.35M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$768.46M
Debt to Assets Ratio
0.24%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Achieve Life Sciences, Inc. (ACHV) | $736.07M | 7.85% | 24.97% | 31.75% | 37.25% |
| Anteris Technologies Global Corp. (AVR)vs › | $726.81M | 0.01% | N/A | N/A | N/A |
| Avalo Therapeutics, Inc. (AVTX)vs › | $751.69M | 0.00% | N/A | N/A | N/A |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $717.44M | 0.40% | N/A | N/A | N/A |
| Candel Therapeutics, Inc. (CADL)vs › | $761.28M | 0.24% | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $766.35M | 0.01% | N/A | N/A | N/A |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $768.46M | 0.24% | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $776.24M | 0.24% | N/A | N/A | N/A |
| Helus Pharma Inc. (HELP)vs › | $694.84M | 0.00% | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $786.39M | 0.48% | N/A | N/A | N/A |
Debt/Assets
7.8%
Debt/Equity
N/A
Current Ratio
0.95
Interest Coverage
-67.0x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 7.85% |
| 2026-03-31 | 45.17% |
| 2025-12-31 | 35.79% |
| 2025-09-30 | 19.14% |
| 2025-06-30 | 16.90% |
| 2025-03-31 | 36.41% |
| 2024-12-31 | 25.78% |
| 2024-09-30 | 20.55% |
| 2024-06-30 | 27.23% |
| 2024-03-31 | 24.55% |
| 2023-12-31 | 86.37% |
| 2023-09-30 | 66.89% |
| 2023-06-30 | 54.74% |
| 2023-03-31 | 79.25% |
| 2022-12-31 | 54.05% |
| 2022-09-30 | 66.54% |
| 2022-06-30 | 45.61% |
| 2022-03-31 | 37.50% |
| 2021-12-31 | 31.55% |
| 2021-09-30 | 0.24% |
| 2021-06-30 | 0.24% |
| 2021-03-31 | 0.37% |
| 2020-12-31 | 0.42% |
| 2020-09-30 | 0.81% |
| 2020-06-30 | 1.67% |
| 2020-03-31 | 1.89% |
| 2019-12-31 | 1.72% |
| 2019-09-30 | 5.41% |
| 2019-06-30 | 3.08% |
| 2019-03-31 | 3.44% |
| 2018-12-31 | 0.18% |
| 2018-09-30 | 0.24% |
| 2018-06-30 | 0.24% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.27% |
| 2017-09-30 | 0.36% |
| 2017-06-30 | 0.46% |
| 2017-03-31 | 0.49% |
| 2016-12-31 | 0.39% |
| 2016-09-30 | 0.35% |
| 2016-06-30 | 0.33% |
| 2016-03-31 | 0.29% |
| 2015-12-31 | 0.27% |
| 2015-09-30 | 0.25% |
| 2015-06-30 | 0.29% |
| 2015-03-31 | 0.39% |
| 2014-12-31 | 0.44% |
| 2014-09-30 | 6.36% |
| 2014-06-30 | 8.45% |
| 2014-03-31 | 8.87% |
| 2013-12-31 | 8.32% |
| 2013-09-30 | 7.82% |
| 2013-06-30 | 7.21% |
| 2013-03-31 | 6.87% |
| 2012-12-31 | 6.51% |
| 2012-09-30 | 7.41% |
| 2012-06-30 | 6.85% |
| 2012-03-31 | 6.60% |
| 2011-12-31 | 11.40% |
| 2011-09-30 | 10.58% |
| 2011-06-30 | 10.05% |
| 2011-03-31 | 1.54% |
| 2010-12-31 | 8.91% |
| 2010-09-30 | 17.38% |
| 2010-06-30 | 36.32% |
| 2010-03-31 | 8.39% |
| 2009-12-31 | 7.31% |
| 2009-09-30 | 11.83% |
| 2009-06-30 | 26.71% |
| 2009-03-31 | 14.24% |
| 2008-12-31 | 12.38% |
| 2008-09-30 | 10.21% |
| 2008-06-30 | 2.69% |
| 2008-03-31 | 2.03% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.02% |
| 2006-09-30 | 0.03% |
| 2006-06-30 | 0.39% |
| 2006-03-31 | 0.07% |
| 2005-12-31 | 0.07% |
| 2005-09-30 | 0.20% |
| 2005-06-30 | 0.43% |
| 2005-03-31 | 0.48% |
| 2004-12-31 | 0.53% |
| 2004-09-30 | 0.60% |
| 2004-06-30 | 0.65% |
| 2004-03-31 | 1.26% |
| 2003-12-31 | 1.27% |
| 2003-09-30 | 1.29% |
| 2003-06-30 | 2.64% |
| 2003-03-31 | 2.41% |
| 2002-12-31 | 2.28% |
| 2002-09-30 | 2.11% |
